The United States genetic testing market presents lucrative growth opportunities driven by increasing disease prevalence, technological advancements, and supportive regulatory frameworks.

Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters due to its strong, consistent performance in high-growth areas. In recent years, the company has built a significant ...

NEW YORK – Laboratory Corporation of America and Natera this week reached an agreement to settle their genetic testing patent infringement dispute. On Wednesday, US District Judge Gregory Williams for ...

The "United States Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.

Noridian Healthcare Solutions opened a draft local coverage determination for gene tests for heritable thoracic aortic disease per a request from Invitae Corp., of San Francisco, which makes a ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Please provide your email address to receive an email when new articles are posted on . Historically marginalized populations may see underdiagnosed rates of inborn errors of immunity. Barriers beyond ...

The "Global Non-Invasive Prenatal Testing Market Report by Application Component End User Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering. Global ...

DUBLIN--(BUSINESS WIRE)--The "Global Non-Invasive Prenatal Testing Market Report by Application Component End User Countries and Company Analysis, 2024-2032" report has been added to ...

BURLINGTON, N.C., Aug. 5, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select ...

SAN FRANCISCO, July 22, 2024 /PRNewswire/ -- Invitae (OTC: NVTAQ), a leading medical genetics company, today announced the launch of its Unlock™ Behind the Seizure ® program, which provides accessible ...